Evolution-Guided Engineering of Non-conserved N -Glycosylation Sites Improves Heterologous Production of Sulfotransferases
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Escherichia coli features low cost, mature fermentation technology and high recombinant protein output, but the expression of glycosylation-dependent eukaryotic proteins therein is severely limited. Many glycosylated proteins are key tool enzymes for the biosynthesis of various pharmaceutical molecules, such as glycosaminoglycan-related synthases, but there is a lack of universal protein engineering methods to enable the adaptive evolution of these enzymes in E. coli . We established an evolution-guided optimization strategy that targets non-conserved N -glycosylation sites (EGO- N Gly). The core of this strategy lies in the phylogeny-guided selective reversion of evolutionarily acquired N -glycosylation sequons to naturally occurring non-glycosylated residues from early-divergent orthologs, thereby improving heterologous production and residual activity stability for selected sulfotransferases in E. coli . Using heparin 3- O -sulfotransferase 1 (3OST-1) as a model enzyme apparatus in eukaryotic organisms, EGO- N Gly extended the residual activity half-life by 4.5-fold. Structural analysis and molecular dynamics simulations indicate that greater surface rigidity and remodeling of intramolecular interaction networks contribute to the improved conformational stability of M7 in an aglycosylated host. EGO- N Gly was further applied to a panel of 3OST and 6OST homologs, demonstrating its applicability to a subset of the tested enzymes. Furthermore, EGO- N Gly can be orthogonally integrated with other complementary protein engineering strategies, as exemplified by its combination with the machine learning-aided Protein Repair One-Stop Service, generating variants with 8-fold and 17-fold extensions in residual activity half-life. Collectively, these results establish EGO- N Gly as a practical and potentially cost-effective engineering strategy for improving the prokaryotic expression and functional performance of selected glycosylation-dependent eukaryotic sulfotransferases.
Significance Statement
Escherichia coli lacks rational engineering methods for the heterologous expression of glycosylation-dependent eukaryotic proteins. We developed an evolution-guided optimization of N -glycosylation (EGO- N Gly) strategy that reverts non-conserved glycosylation sequons to the non-glycosylated residues conserved in early-divergent orthologs, improving the heterologous expression, catalytic function, and stability of animal-derived sulfotransferases. In heparin 3- O -sulfotransferase 1, EGO- N Gly extended the residual activity half-life at 37 °C by 4.5-fold. The strategy was transferable to several additional sulfotransferase homologs in a sequence-context-dependent manner and could be combined with machine-learning aided stability design to further extend the half-life by up to 17-fold. EGO- N Gly thus provides a practical and potentially cost-effective strategy for improving the prokaryotic production of selected animal-derived sulfotransferases.